2005•European Archives of Psychiatry and Clinical NeuroscienceRequires access

Is dose escalation of antidepressants a rational strategy after a medium–dose treatment has failed?

Mazda Adli, Ch. Baethge, Andreas Heinz, Nicolas Langlitz, Michael Bauer

Open publisher page 176 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 176 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Tranylcypromine, Medicine, Antidepressant, Monoamine oxidase inhibitor, Refractory (planetary science), Tricyclic, Pharmacology, Clinical trial

Back to paper search Browse research topics Original source

Is dose escalation of antidepressants a rational strategy after a medium–dose treatment has failed? — Research Paper | ScholarLens